Zhongchao (NASDAQ:ZCMD) Downgraded by Wall Street Zen to “Sell”
by Jessica Moore · The Cerbat GemWall Street Zen cut shares of Zhongchao (NASDAQ:ZCMD – Free Report) from a hold rating to a sell rating in a research note released on Saturday,Wall Street Zen reports.
Separately, Weiss Ratings raised Zhongchao from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, August 24th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has an average rating of “Sell”.
Check Out Our Latest Research Report on Zhongchao
Zhongchao Price Performance
Shares of NASDAQ:ZCMD opened at $0.76 on Friday. Zhongchao has a 12 month low of $0.71 and a 12 month high of $967.20. The company’s 50-day moving average price is $1.14 and its two-hundred day moving average price is $72.97.
Zhongchao Company Profile
Zhongchao Inc provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand.
Featured Stories
- Five stocks we like better than Zhongchao
- Lennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. Housing
- Priced for a Pullback or More Gains? These 3 Stocks Are Testing the Limits
- These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth Stories
- Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike